J Clin Oncol. 2006 Apr 20;24(12):1940-9.

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

Source

Department of Obstetrics and Gynecology, J.W. Goethe-University Hospital, Frankfurt, Germany. M.Kaufmann@em.uni-frankfurt.de

Erratum in

J Clin Oncol. 2006 Jul 1;24(19):3221.

Abstract

Neoadjuvant (primary systemic) treatment is the standard treatment for locally advanced breast cancer and a standard option for primary operable disease. Because of new treatments and new understandings of breast cancer, however, recommendations published in 2003 regarding neoadjuvant treatment for operable disease required updating. Therefore, a second international panel of representatives of a number of breast cancer clinical research groups was convened in September 2004 to update these recommendations. As part of this effort, data published to date were reviewed critically and indications for neoadjuvant treatment were newly defined.

PMID:: 16622270; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Practice Guideline

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. [Ann Oncol. 2007]
Review Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H, Colleoni M, Denkert C, Eiermann W, Jackesz R, et al. Ann Oncol. 2007 Dec; 18(12):1927-34. Epub 2007 Nov 12.
Review International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. [J Clin Oncol. 2003]
Review International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P, Untch M, et al. J Clin Oncol. 2003 Jul 1; 21(13):2600-8.
Review [New combination chemotherapy regimens in the primary treatment of operable breast cancer]. [Clin Ter. 2007]
Review [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F, Sergi D, Foggi P, Abbate MI, Lopez M. Clin Ter. 2007 Jan-Feb; 158(1):55-75.
Neoadjuvant tamoxifen for operable breast cancer: a need for phase III studies? [Cancer Detect Prev. 2000]
Neoadjuvant tamoxifen for operable breast cancer: a need for phase III studies?
Pujol P, Daures JP, Rouanet P, Hermand J, Domergue J, Grenier J, Maudelonde T. Cancer Detect Prev. 2000; 24(5):445-51.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Med Biol. 2007]
Review Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Adv Exp Med Biol. 2007; 608:1-22.

See reviews... See all...

Cited by 19 PubMed Central articles

Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium. [J Thorac Dis. 2010]
Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.
Papademetriou K, Ardavanis A, Kountourakis P. J Thorac Dis. 2010 Sep; 2(3):160-70.
Comparison of Doxorubicin plus docetaxel neoadjuvant chemotherapy with Doxorubicin plus vinorelbine in primary breast cancer. [J Breast Cancer. 2011]
Comparison of Doxorubicin plus docetaxel neoadjuvant chemotherapy with Doxorubicin plus vinorelbine in primary breast cancer.
Gwak G, Kim JY, Park K, Shin YJ, Cho H, Park SJ, Yang GH, Bae BN, Kim KW, Han S. J Breast Cancer. 2011 Jun; 14(2):129-34. Epub 2011 Jun 18.
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. [Ann Oncol. 2011]
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ, Panel members. Ann Oncol. 2011 Aug; 22(8):1736-47. Epub 2011 Jun 27.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Recommendations from an international expert panel on the use of neoadjuvant (pr...
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
J Clin Oncol. 2006 Apr 20 ;24(12):1940-9.

PubMed
Bisphosphonate action. Alendronate localization in rat bone and effects on osteo...
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
J Clin Invest. 1991 Dec ;88(6):2095-105.

PubMed
Essential dosage-dependent functions of the transcription factor yin yang 1 in l...
Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression.
Mol Cell Biol. 2006 May ;26(9):3565-81.

PubMed
Growth factors and cancer.
Growth factors and cancer.
Science. 1991 Nov 22 ;254(5035):1146-53.

PubMed
Trastuzumab: a review of its use in the management of HER2-positive metastatic a...
Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer.
Drugs. 2006 ;66(4):449-75.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: